JP2008517946A5 - - Google Patents

Download PDF

Info

Publication number
JP2008517946A5
JP2008517946A5 JP2007538167A JP2007538167A JP2008517946A5 JP 2008517946 A5 JP2008517946 A5 JP 2008517946A5 JP 2007538167 A JP2007538167 A JP 2007538167A JP 2007538167 A JP2007538167 A JP 2007538167A JP 2008517946 A5 JP2008517946 A5 JP 2008517946A5
Authority
JP
Japan
Prior art keywords
cells
antigen
cancer cells
heat
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007538167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008517946A (ja
JP5623004B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/038360 external-priority patent/WO2006047515A2/en
Publication of JP2008517946A publication Critical patent/JP2008517946A/ja
Publication of JP2008517946A5 publication Critical patent/JP2008517946A5/ja
Application granted granted Critical
Publication of JP5623004B2 publication Critical patent/JP5623004B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007538167A 2004-10-25 2005-10-25 熱ショックをかけたメラノーマ細胞体が装填された樹状細胞 Expired - Lifetime JP5623004B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62195704P 2004-10-25 2004-10-25
US60/621,957 2004-10-25
PCT/US2005/038360 WO2006047515A2 (en) 2004-10-25 2005-10-25 Dendritic cells loaded with heat shocked melanoma cell bodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012197756A Division JP5894891B2 (ja) 2004-10-25 2012-09-07 熱ショックをかけたメラノーマ細胞体が装填された樹状細胞

Publications (3)

Publication Number Publication Date
JP2008517946A JP2008517946A (ja) 2008-05-29
JP2008517946A5 true JP2008517946A5 (enExample) 2008-12-11
JP5623004B2 JP5623004B2 (ja) 2014-11-12

Family

ID=36228381

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007538167A Expired - Lifetime JP5623004B2 (ja) 2004-10-25 2005-10-25 熱ショックをかけたメラノーマ細胞体が装填された樹状細胞
JP2012197756A Expired - Lifetime JP5894891B2 (ja) 2004-10-25 2012-09-07 熱ショックをかけたメラノーマ細胞体が装填された樹状細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012197756A Expired - Lifetime JP5894891B2 (ja) 2004-10-25 2012-09-07 熱ショックをかけたメラノーマ細胞体が装填された樹状細胞

Country Status (5)

Country Link
US (5) US20060140983A1 (enExample)
EP (1) EP1814981A4 (enExample)
JP (2) JP5623004B2 (enExample)
CN (1) CN101052709B (enExample)
WO (1) WO2006047515A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2950109C (en) 2000-10-27 2019-02-19 John W. Hadden Vaccine immunotherapy for immune suppressed patients
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
CN101511384A (zh) * 2006-06-30 2009-08-19 贝勒研究院 采用GM-CSF和α干扰素制成的并装载热处理的且杀死的癌细胞的树突状细胞
CL2007002825A1 (es) * 2007-09-28 2008-05-30 Univ De Chile Oncobiomed Metodo para generar vacunas que estimulen el sistema inmune que comprende inducir celulas mononucleares de sangre periferica a que se diferencien a apc, para luego, separar dichas apc y mezclarlas con adyuvantes; extracto de celulas tumorales; y comp
AU2009251277A1 (en) * 2008-05-29 2009-12-03 Irx Therapeutics, Inc. Mechanism of action of primary cell derived biologic
CN102076354A (zh) * 2008-07-03 2011-05-25 杜克大学 用于引发免疫应答的组合物和方法
US20100215697A1 (en) * 2009-02-26 2010-08-26 Stanimir Vuk-Pavlovic Methods and materials for making and using vaccines
AU2010248761B2 (en) 2009-05-15 2016-02-11 Irx Therapeutics, Inc. Vaccine immunotherapy
CN107050430B (zh) 2009-12-08 2021-10-15 伊尔克斯治疗有限公司 逆转朗格汉斯细胞免疫抑制的方法
EP2543386A1 (en) 2011-07-05 2013-01-09 Sotio a.s. Means and methods for active cellular immunotherapy of cancer by using tumor cells killed by high hydrostatic pressure
US20130011438A1 (en) 2011-07-05 2013-01-10 SOTIO a.s. Means And Methods For Active Cellular Immunotherapy Of Cancer By Using Tumor Cells Killed By High Hydrostatic Pressure and Dendritic Cells
SG11201401631VA (en) * 2011-10-20 2014-05-29 California Stem Cell Inc Antigen presenting cancer vaccine with gamma interferon
CN102552891A (zh) * 2011-12-27 2012-07-11 陆华 热休克凋亡脑胶质瘤负载树突状细胞肿瘤疫苗的制备方法
CA2863653A1 (en) * 2012-02-02 2013-08-08 California Stem Cell, Inc. Pluripotent germ layer origin antigen presenting cancer vaccine
US20140065173A1 (en) * 2012-09-06 2014-03-06 Orbis Health Solutions Llc Tumor lysate loaded particles
WO2015040230A1 (en) * 2013-09-23 2015-03-26 Koninklijke Philips N.V. Medical apparatus for treating cells with vibrations
FR3011850B1 (fr) * 2013-10-15 2018-04-06 Cfl Biotech Vaccin therapeutique contre le cancer a base de proteines de stress rendues immunogenes
US9562219B2 (en) 2013-12-27 2017-02-07 SOTIO a.s. Cryopreservation of apoptotic cancer cells for use in immunotherapy against cancer
EP3113759B1 (en) 2014-03-05 2021-05-12 Orbis Health Solutions LLC Vaccine delivery systems using yeast cell wall particles
JP6436669B2 (ja) * 2014-07-22 2018-12-12 国立大学法人福井大学 子宮肉腫転移モデル動物
US11364264B2 (en) 2016-09-09 2022-06-21 The General Hospital Corporation Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer
IL268744B2 (en) * 2017-02-17 2024-08-01 Aivita Biomedical Inc Methods for increasing the immunogenicity of tumors and preparations for autologous immunotherapeutic products against cancer using tumor cells and adapted dendritic cells
WO2026076308A1 (en) * 2024-10-03 2026-04-09 Ne1 Inc. Cancer vaccine and method of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320111A (en) * 1977-06-14 1982-03-16 American Home Products Corporation Immunologic compositions methods of preparation and use
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US5750119A (en) * 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
US6300090B1 (en) * 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
US6734014B1 (en) * 1996-02-08 2004-05-11 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for transforming dendritic cells and activating T cells
US6455493B1 (en) * 1996-09-20 2002-09-24 University Of New Mexico Methods for using heat shock proteins
US5830464A (en) * 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
WO1999042564A2 (en) * 1998-02-20 1999-08-26 The Rockefeller University Apoptotic cell-mediated antigen presentation to dendritic cells
WO2001083713A2 (en) * 2000-04-28 2001-11-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education The use of tolerogenic dendritic cells for enhancing tolerogenicity in a host and methods for making the same
EP1209226A3 (en) * 2000-11-07 2002-06-05 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70)
AU2003260426A1 (en) * 2002-08-16 2004-03-11 Glycotope Gmbh Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds
AU2003285863A1 (en) * 2002-10-09 2004-05-04 Central Iowa Health System Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase

Similar Documents

Publication Publication Date Title
EP3917560A1 (en) Pharmaceutical composition for use in the treatment of pancreatic cancer
JP2013177430A5 (enExample)
CN1738619B (zh) 给予体外部分成熟的树突细胞治疗肿瘤的制药用途
US20170296639A1 (en) Method for preparing dendritic cell loaded with antigen
Huang et al. Reactive oxygen species-sensitive biodegradable mesoporous silica nanoparticles harboring TheraVac elicit tumor-specific immunity for colon tumor treatment
JP2009531152A5 (enExample)
EP2185686B1 (en) Dendritic cells
AU2003296439B2 (en) In situ maturation of dendritic cells
CN106589133A (zh) 一种新的增强型抗原联合多肽诱导肝癌特异性ctl细胞的制备及应用
Li et al. Targeting of Low‐Immunogenic Poly (ethylene glycol) Nanoparticles for Photothermal‐Enhanced Immunotherapy
CA3127997A1 (en) Pharmaceutical composition for use in the treatment of pancreatic cancer
EP4142751A1 (en) Fibroblast mediated expansion and augmentation of immune regulatory cells for treatment of acute respiratory distress syndrome (ards)
CN113332452A (zh) pH/还原/温度三重刺激响应的共载免疫佐剂和吲哚箐绿聚合物囊泡及其制备方法和应用
CN107029224B (zh) 一种免疫增强抗肿瘤胶原组合物、制备方法及其应用
CN101984978B (zh) 一种复合辅酶药的制备方法
WO2017071379A1 (zh) 一种用于治疗胃癌的肿瘤疫苗及其制备方法
CN119367521A (zh) 一种治疗乳腺癌的多功能自体仿生纳米疫苗及其制备方法和应用
CA2320969A1 (en) Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes
CN113430165A (zh) 一种负载thc的干细胞载药系统及其制备方法
CN103495180B (zh) 一种猪繁殖与呼吸综合征复合活疫苗用冻干保护剂
CN102526751A (zh) 一种猪瘟脾淋源活疫苗耐热冻干保护剂及制备方法
CN118384184A (zh) 一种经修饰的免疫细胞外泌体组合物及其制备方法
CN117024568A (zh) 一种atp响应型疫苗功能化框架核酸及其应用
CN113384689A (zh) 一种硼烯纳米疫苗及其制备方法和应用
NL2024515B1 (en) Pharmaceutical composition for use in the treatment of pancreatic cancer